| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
5,492 |
5,004 |
$1.66M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,709 |
7,065 |
$1.55M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,586 |
8,029 |
$1.34M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,957 |
1,580 |
$337K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
4,502 |
3,803 |
$205K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,778 |
2,286 |
$164K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,395 |
1,861 |
$155K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
17,215 |
14,401 |
$147K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,653 |
3,078 |
$137K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
182 |
174 |
$131K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,800 |
2,491 |
$129K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
2,036 |
842 |
$95K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,231 |
1,324 |
$93K |
| 80053 |
Comprehensive metabolic panel |
8,087 |
6,879 |
$85K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
109 |
107 |
$84K |
| 36415 |
Collection of venous blood by venipuncture |
15,330 |
13,060 |
$60K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,519 |
1,421 |
$58K |
| G0378 |
Hospital observation service, per hour |
178 |
85 |
$43K |
| 71046 |
Radiologic examination, chest; 2 views |
777 |
716 |
$39K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
487 |
462 |
$37K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,441 |
4,267 |
$33K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
286 |
243 |
$32K |
| 70450 |
Computed tomography, head or brain; without contrast material |
89 |
86 |
$30K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
822 |
751 |
$29K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,164 |
611 |
$27K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,074 |
1,020 |
$27K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,088 |
884 |
$25K |
| 94760 |
|
4,809 |
4,457 |
$23K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
395 |
381 |
$22K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,350 |
1,297 |
$21K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
321 |
313 |
$21K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
158 |
152 |
$20K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
147 |
118 |
$19K |
| 59025 |
Fetal non-stress test |
132 |
91 |
$18K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
49 |
47 |
$18K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
643 |
625 |
$18K |
| 94761 |
|
7,920 |
7,229 |
$17K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
202 |
198 |
$16K |
| 76830 |
Ultrasound, transvaginal |
139 |
134 |
$14K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
642 |
624 |
$14K |
| 97161 |
|
281 |
274 |
$14K |
| 81001 |
|
2,290 |
2,104 |
$14K |
| 84484 |
|
701 |
563 |
$13K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
119 |
115 |
$13K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
137 |
133 |
$12K |
| 97162 |
|
264 |
253 |
$12K |
| 96376 |
|
134 |
104 |
$12K |
| 93975 |
|
68 |
63 |
$12K |
| 80061 |
Lipid panel |
738 |
717 |
$11K |
| 87081 |
|
590 |
573 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,038 |
972 |
$11K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,226 |
1,143 |
$11K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
46 |
27 |
$11K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,179 |
1,753 |
$10K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,292 |
1,093 |
$10K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
233 |
209 |
$9K |
| 84703 |
|
570 |
540 |
$9K |
| 83690 |
|
409 |
367 |
$9K |
| 85027 |
|
1,256 |
1,186 |
$9K |
| 87186 |
|
224 |
214 |
$8K |
| 82728 |
|
364 |
354 |
$7K |
| 71045 |
Radiologic examination, chest; single view |
147 |
126 |
$7K |
| 85610 |
|
420 |
269 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
110 |
97 |
$6K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,165 |
894 |
$6K |
| 0012A |
|
239 |
217 |
$5K |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
111 |
106 |
$5K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
182 |
180 |
$5K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
48 |
25 |
$5K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
226 |
222 |
$5K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,111 |
1,436 |
$5K |
| 86803 |
|
128 |
124 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
154 |
132 |
$5K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
12 |
12 |
$5K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
120 |
114 |
$5K |
| 0240U |
|
100 |
95 |
$4K |
| 73630 |
|
80 |
73 |
$4K |
| 73610 |
|
75 |
68 |
$4K |
| 83605 |
|
96 |
85 |
$4K |
| 0450 |
Emergency room services |
96 |
84 |
$4K |
| 0011A |
|
209 |
191 |
$3K |
| 81003 |
|
610 |
564 |
$3K |
| 73562 |
|
55 |
53 |
$3K |
| J2704 |
Injection, propofol, 10 mg |
1,185 |
981 |
$3K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
90 |
89 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
251 |
247 |
$3K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
60 |
54 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,399 |
1,146 |
$2K |
| 73130 |
|
32 |
28 |
$2K |
| 87070 |
|
80 |
77 |
$2K |
| 87077 |
|
101 |
98 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
544 |
510 |
$2K |
| 76536 |
|
12 |
12 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
221 |
159 |
$2K |
| 86850 |
|
116 |
111 |
$2K |
| 80329 |
|
14 |
13 |
$2K |
| 94060 |
|
12 |
12 |
$2K |
| 86592 |
|
102 |
102 |
$2K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
54 |
29 |
$2K |
| 80320 |
|
31 |
30 |
$2K |
| 82948 |
|
347 |
226 |
$2K |
| 85379 |
|
38 |
36 |
$1K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
350 |
328 |
$1K |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
84 |
79 |
$1K |
| 73030 |
|
28 |
26 |
$1K |
| 87088 |
|
117 |
111 |
$1K |
| 74018 |
|
16 |
14 |
$1K |
| 84153 |
|
47 |
42 |
$1K |
| 73110 |
|
17 |
13 |
$1K |
| 81025 |
|
234 |
217 |
$1K |
| 80076 |
|
100 |
93 |
$835.86 |
| 87040 |
|
20 |
12 |
$798.75 |
| 87807 |
|
15 |
15 |
$796.80 |
| 83735 |
|
109 |
66 |
$746.29 |
| J3535 |
Drug administered through a metered dose inhaler |
15 |
15 |
$653.37 |
| 88342 |
|
12 |
12 |
$592.36 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
170 |
134 |
$567.82 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
163 |
139 |
$517.09 |
| 87340 |
|
33 |
33 |
$516.88 |
| 86900 |
|
45 |
41 |
$487.52 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
181 |
151 |
$484.30 |
| 97803 |
|
15 |
15 |
$413.82 |
| 85651 |
|
27 |
27 |
$397.46 |
| J7999 |
Compounded drug, not otherwise classified |
29 |
29 |
$365.30 |
| 82947 |
|
34 |
34 |
$354.38 |
| 86901 |
|
43 |
40 |
$349.19 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
371 |
175 |
$329.55 |
| J2060 |
Injection, lorazepam, 2 mg |
53 |
46 |
$295.93 |
| 83540 |
|
17 |
16 |
$279.20 |
| 83550 |
|
17 |
16 |
$277.98 |
| 86787 |
|
14 |
14 |
$271.08 |
| 84439 |
|
16 |
16 |
$269.24 |
| 87210 |
|
17 |
17 |
$221.01 |
| 0353U |
|
26 |
25 |
$207.92 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
12 |
12 |
$202.53 |
| 82043 |
|
14 |
14 |
$199.68 |
| 86762 |
|
12 |
12 |
$140.17 |
| 81015 |
|
12 |
12 |
$117.00 |
| A9270 |
Non-covered item or service |
15 |
15 |
$67.11 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
100 |
67 |
$35.55 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
12 |
12 |
$26.11 |
| A9150 |
Non-prescription drugs |
17 |
17 |
$4.44 |
| 82962 |
|
38 |
25 |
$3.22 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,554 |
1,210 |
$0.10 |
| A7038 |
Filter, disposable, used with positive airway pressure device |
54 |
54 |
$0.00 |
| E0562 |
Humidifier, heated, used with positive airway pressure device |
12 |
12 |
$0.00 |